Why Did Trimix Cause Priapism? (TRT Q&As)
Timeline
Dr. O’Connor explains that Trimix is a powerful erectile dysfunction treatment and that prolonged erections can become a medical emergency. He stresses careful dosing and cautions about combining injectable erectile medications with other vasodilating drugs.
Dr. O’Connor explains that topical sildenafil or alprostadil generally has less systemic absorption than an injection, but excessive use or combining multiple erectile medications could still increase the risk of priapism. He recommends caution, particularly in someone who has already had an unusually strong response to Trimix.
Dr. O’Connor says the dramatic cholesterol increase warrants repeat testing and a full cardiovascular evaluation rather than assuming TRT alone is responsible. He emphasizes advanced lipid testing, coronary calcium findings, controlling the ABCDs, reducing unnecessary androgen exposure, and discussing appropriate lipid-lowering treatment with the patient’s physician.
The member wants a more economical TRT arrangement that allows him to fill testosterone at a local pharmacy. Dr. O’Connor explains that state licensing and telemedicine requirements can complicate care across state lines and suggests checking whether a Certified Testosteronologist® licensed for multiple states can legally provide care in Arizona.
Dr. O’Connor discusses how drugs such as Masteron, Primobolan, and Anavar can affect the limbic system, libido, erections, and sexual sensation differently from person to person. His usual approach is to stop the additional steroid, remain on an appropriate testosterone regimen when indicated, and allow time for the nervous and hormonal systems to reset.
Dr. O’Connor explains that androgen-induced erythrocytosis can be difficult to manage because repeated phlebotomy may deplete iron while testosterone continues stimulating red blood cell production. He recommends evaluating the underlying causes, including possible hereditary hemochromatosis and sleep apnea, while individualizing testosterone dosing, blood donation, and cardiovascular risk management.
Video Summary
Andrew addresses questions about inconsistent response to testosterone therapy and the urge to make rapid protocol changes. He explains how lab timing, assay variability, and physiologic adaptation influence perceived effectiveness. The discussion reinforces patience as a prerequisite for clarity.
Estradiol interpretation becomes a central theme, with emphasis on distinguishing physiologic variation from true excess. Andrew cautions against reflexive suppression strategies driven solely by lab numbers. Symptoms are framed as signals that must be evaluated alongside objective data.
Later questions expand to recovery and training stress, illustrating how lifestyle strain can mimic hormonal issues. The episode presents testosterone care as a longitudinal process guided by trend analysis and clinical judgment. Incremental adjustments are emphasized to preserve stability.
Condition Callouts
Key Takeaways
- Symptom variability early in testosterone therapy often resolves without immediate protocol changes.
- Estradiol levels should be interpreted alongside symptoms rather than treated reflexively.
- Lab timing and assay consistency are essential for reliable hormone assessment.
- Recovery deficits and training stress can mimic endocrine dysfunction.
- Incremental, data-driven adjustments support durable hormonal stability.